NeoStem
420 Lexington Avenue
Suite 350
New York, New York 10170
Telephone: 1.212.584.4180

Corporate Governance

NeoStem’s business is conducted by its senior executives and employees, with oversight from the board of directors. The Board’s Nominating and Governance Committee periodically reviews the company’s corporate governance principles and current practices. The Board’s Audit and Compensation Committees are led by independent directors. The Board has adopted a Code of Ethics and Code of Ethics for Senior Financial Officers to focus the Board and each director on areas of ethical risk, provide guidance to help them continue to effectively recognize and deal with ethical issues, enhance existing mechanisms to continue the reporting of unethical conduct, and help to continue to foster and sustain a culture of honesty and accountability.

Ethics

Committees

NeoStem - Cell Therapy Development - Investors